Mashukur Rahman/LinkedIn
Feb 8, 2026, 14:09
Mashukur Rahman: New ESC Dyslipidemia Updates Expand the Role of Statins
Mashukur Rahman, Resident Doctor at Bangladesh Medical University, Medical Officer at Directorate General of Health Services, shared a post on LinkedIn.
“Many doctors still think statins are only for high LDL cholesterol.
But the new ESC dyslipidemia updates suggest a bigger role.
Why this matters now:
- Statins may help protect the heart in some cancer patients.
Some chemotherapy drugs like anthracyclines can cause heart failure years later. Preventive statin use is getting stronger support. - We are moving from treating numbers to treating overall risk.
Risk builds silently, even when LDL is not very high.
In real life, we often wait for LDL to cross a ‘clear cutoff.’
But by then, damage may already be starting.
If statins are becoming broader heart-protection drugs — when should we start them in borderline-risk patients?”
Stay updated with Hemostasis Today.
-
Sep 10, 2026, 11:56William Pao: Celebrating a Landmark Breakthrough in Hemophilia Care
-
Sep 10, 2026, 11:25Andreas Glenthøj: New Sickle Cell Trait Data in UpToDate
-
Sep 10, 2026, 10:53A New Era of Hemophilia Screening and Diagnosis in Women and Girls – ISTH
-
Sep 10, 2026, 10:03Investing in Youth, Transforming Hemophilia Care – WFH
-
Sep 10, 2026, 09:51Ronke Oke BEM: 20 Years of Newborn Sickle Cell Screening in England
-
Sep 10, 2026, 09:41Seunghwan Song: Hemlibra and the Science That Changed Hemophilia A Care
-
Sep 10, 2026, 09:20Mark Dawson: A Radical Rethink of Hemophilia Treatment
-
Sep 10, 2026, 07:26Carly Newton: Every Donation Helps Save Lives
-
Sep 10, 2026, 07:152023 ACR/EULAR APS Classification Criteria – APS Foundation of America